We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $174B
1-Year Est. Return 30.96%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+30.96%
3 Year Est. Return
+104.8%
5 Year Est. Return
+143.7%
10 Year Est. Return
+536.36%
AUM
$84.3B
AUM Growth
+$3.94B
Cap. Flow
+$1.99B
Cap. Flow %
2.36%
Top 10 Hldgs %
16.61%
Holding
2,631
New
97
Increased
1,346
Reduced
213
Closed
73

Top Buys

Rank Stock Value
1
DXC icon
DXC Technology
DXC
+$79.7M
2
DELL icon
Dell
DELL
+$72.6M
3
RAI
Reynolds American Inc
RAI
+$63.3M
4
MSFT icon
Microsoft
MSFT
+$54.9M
5
MO icon
Altria Group
MO
+$53.8M

Sector Composition

Rank Sector Weight
1 Technology 16.83%
2 Healthcare 15.56%
3 Consumer Discretionary 10.99%
4 Communication Services 10.5%
5 Industrials 10.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULH icon
2551
Universal Logistics Holdings
ULH
$529M
$213K ﹤0.01%
14,170
SDRL
2552
DELISTED
Seadrill Limited Common Stock
SDRL
$211K ﹤0.01%
2,156
JNCE
2553
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$188K ﹤0.01%
+13,400
New +$287K
CSLT
2554
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$165K ﹤0.01%
39,650
NGVC icon
2555
Vitamin Cottage Natural Grocers
NGVC
$654M
$156K ﹤0.01%
18,900
XBIT icon
2556
XBiotech
XBIT
$69.2M
$148K ﹤0.01%
31,500
GEN
2557
DELISTED
Genesis Healthcare, Inc.
GEN
$128K ﹤0.01%
73,500
ARWR icon
2558
Arrowhead Research
ARWR
$12.4B
-91,400
Closed -$169K
CBOE icon
2559
Cboe Global Markets
CBOE
$29.9B
-165,700
Closed -$13.4M
CLSD
2560
DELISTED
Clearside Biomedical
CLSD
-1,880
Closed -$224K
CM icon
2561
Canadian Imperial Bank of Commerce
CM
$108B
$0 ﹤0.01%
+2
New +$81
DHX icon
2562
DHI Group
DHX
$173M
-81,300
Closed -$321K
DK icon
2563
Delek US
DK
$3.58B
-81,400
Closed -$1.98M
EWBC icon
2564
East-West Bancorp
EWBC
$18B
-238,160
Closed -$12.3M
IBRX icon
2565
ImmunityBio
IBRX
$8.1B
-42,450
Closed -$151K
MNKD icon
2566
MannKind Corp
MNKD
$1.32B
-92,620
Closed -$137K
PMTS icon
2567
CPI Card Group
PMTS
$320M
-5,460
Closed -$115K
SPWH icon
2568
Sportsman's Warehouse
SPWH
$46M
-50,800
Closed -$243K
TPST icon
2569
Tempest Therapeutics
TPST
$14.6M
-15
Closed -$83K
ZION icon
2570
Zions Bancorporation
ZION
$10.3B
-337,100
Closed -$14.2M
TCS
2571
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
-2,023
Closed -$128K
ASXC
2572
DELISTED
Asensus Surgical, Inc.
ASXC
-5,669
Closed -$89K
TRVN
2573
DELISTED
Trevena, Inc.
TRVN
-90
Closed -$206K
ISEE
2574
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-42,622
Closed -$156K
SRNE
2575
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-75,764
Closed -$299K

Similar funds

Swiss National Bank's Q2 2017 Portfolio in Review

As of Q2 2017, Swiss National Bank held 2,631 positions worth $84.3B, up 4.9% from $80.4B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Swiss National Bank's Q2 2017 filing shows 97 new, 1,346 increased, 213 reduced and 73 closed positions. Its largest new stake was DXC Technology: 1,200,928 shares worth $79.7M. The largest sale was Yahoo Inc, an estimated $149M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Swiss National Bank's largest Q2 2017 buy was DXC Technology: 1,200,928 shares worth $79.7M.
  • Swiss National Bank added most to Dell in Q2 2017, an estimated $72.6M increase.
  • Swiss National Bank's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $63.3M.
  • Swiss National Bank fully exited Yahoo Inc in Q2 2017, selling an estimated $149M.
  • Swiss National Bank's ten largest holdings make up 17% of its $84.3B portfolio in Q2 2017.
  • Swiss National Bank opened 97 new positions and closed 73 in Q2 2017.
  • Swiss National Bank's portfolio value rose 4.9% quarter-over-quarter to $84.3B.

Based on Swiss National Bank's 13F filing for Q2 2017, filed 9 Aug 2017.